Key Financial’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
Other funds holding CYTK
Key Financial's CYTK Position: Q3 2026 in Review
Key Financial held its Cytokinetics (CYTK) position steady in Q3 2026 at 200 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #803.
Key Financial first reported a position in CYTK in Q4 2025 and has held it in 4 quarters since. The position peaked at $17K in Q2 2026. 348 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.
- Key Financial held 200 shares of Cytokinetics worth $13.2K as of Q3 2026.
- Key Financial left its Cytokinetics share count unchanged in Q3 2026.
- Cytokinetics made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #803 holding.
- Key Financial first reported a position in Cytokinetics in Q4 2025 and has held it in 4 quarters since.
- Key Financial's Cytokinetics position peaked at $17K in Q2 2026.
- 348 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.